About this episode

The episode discusses key lung cancer trials and data presented at the 2026 ASCO Annual Meeting.

This week, VJOncology brings you lung cancer highlights from the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. Join Alessandro di Federico from the Memorial Sloan Kettering Cancer Center, Erika Ruiz-Garcia of the Instituto Nacional de Cancerologia, Nandini Menon of the Tate Memorial Centre and Bjorn Henning Gronberg of the Norwegian University of Science and Technology as they discuss key trials and data in lung cancer from the meeting. They explore results from the LIBRETTO-432, TRITON and FLAME trials, as well as 7-year follow up data from the CROWN trial. In addition, they discuss two trials of KRAS G12C inhibitors, a study examining low-dose pembrolizumab and a trial of thoracic radiotherapy.

More episodes of VJOncology Podcast

• GU cancer highlights from ASCO 2026 · July 17, 2026 · 17 min
• Top updates from the ESMO Gastrointestinal Cancers Congress 2026 · July 10, 2026 · 19 min
• Breast cancer highlights from ASCO 2026 · June 19, 2026 · 18 min

Explore listener stats, chart rankings, contacts and more on the VJOncology Podcast podcast page.